Under-eye filler—clinically referred to as tear trough filler—is an injectable treatment that uses a gel-like substance, most commonly hyaluronic acid.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Most under-eye fillers are used off-label; only Restylane Eyelight holds specific FDA approval for the tear trough area.
Serious complications are rare but possible—confirm your provider stocks hyaluronidase for emergency reversal.
Not every dark circle or hollow responds to filler; candidacy depends on the underlying cause.
Verify provider credentials, facility accreditation, and an explicit complication-escalation plan before booking.
If traveling for treatment, build at least 7–10 days of post-procedure observation into your itinerary.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
What Is Under-Eye Filler?
Under-eye filler—clinically referred to as tear trough filler—is an injectable treatment that uses a gel-like substance, most commonly hyaluronic acid (HA), to restore volume beneath the eyes. The goal is to soften hollows, reduce shadowing, and create a smoother transition between the lower eyelid and cheek. Results typically last between 6 and 18 months depending on the product, placement depth, and individual metabolism, according to Healthline's overview of tear trough filler.
How Tear Trough Filler Works
A trained injector places small amounts of HA filler beneath the skin along the tear trough—the groove that runs from the inner corner of the eye toward the cheek. The filler adds volume where tissue has thinned, which can reduce the appearance of dark shadows caused by volume loss. Treatments are typically performed in-office with topical numbing and may take 15–30 minutes.
FDA-Approved vs. Off-Label Use
In September 2023, Restylane Eyelight received FDA approval specifically for under-eye rejuvenation, making it the first HA filler with a dedicated indication for this area. Clinical data from the approval trial showed that approximately 87% of participants experienced no adverse effects. Other HA fillers—such as Juvederm Volbella or Restylane-L—are frequently used in the tear trough but are considered "off-label" for this location. Off-label use is common and accepted in aesthetic medicine, though patients should be informed about the distinction.
Off-label does not mean unsafe
Off-label use means a product is used in a way not specifically listed in its FDA labelling. Many widely accepted medical treatments are performed off-label. Your provider should explain which product they plan to use and why.
How Long Results Last
Duration varies. Most patients can expect results to last roughly 6–18 months. Factors that influence longevity include the specific filler product, the volume injected, individual metabolic rate, and lifestyle factors. Maintenance sessions are typically needed to sustain the effect.
Are You a Good Candidate?
Candidacy for under-eye filler depends on the cause of your concerns. According to clinical guidance on candidacy, patients with genuine volume loss (tear trough deformity) due to aging or genetics tend to respond best to filler treatment.
Ideal Candidate Characteristics
You may be a good candidate if you have:
A visible hollow or groove beneath the eyes caused by volume loss
Good skin elasticity in the under-eye area
Realistic expectations about what filler can and cannot achieve
No active infections or inflammatory skin conditions near the injection site
Festoons or malar bags — filler can worsen puffiness in patients with these conditions
Allergies to HA or lidocaine — most HA fillers contain lidocaine for comfort
Uncontrolled medical conditions — including autoimmune disorders or bleeding disorders
Active skin infections near the treatment area
Pregnancy or breastfeeding — filler is typically deferred during this time
When filler is not the answer
If your provider identifies festoons, significant fat pad herniation, or severe skin laxity, filler alone may not address your concerns—and in some cases can make them worse. A thorough in-person assessment is essential before proceeding.
What Under-Eye Filler Cannot Fix
Under-eye filler specifically addresses volume loss. It does not treat:
Hyperpigmentation — dark circles caused by melanin deposits or vascular visibility
Skin laxity — loose or crepey skin that may need resurfacing or surgical options
Fat pad herniation — protruding fat pads (eye bags) that may require blepharoplasty
Candidacy guidance emphasises that an accurate diagnosis of the underlying cause is the first step toward the right treatment.
Understanding the Risks
All injectable procedures carry some degree of risk. Understanding the range—from common and mild to rare and serious—helps you make a more informed decision.
Common Side Effects and What to Expect
Temporary effects are normal and generally resolve within 1–2 weeks. Healthline notes that these may include:
Bruising at the injection site
Swelling (may be more pronounced on the first few days)
Redness or tenderness
Mild lumpiness that typically settles as the filler integrates
Tyndall Effect and Other Aesthetic Concerns
The Tyndall effect is a bluish discolouration that can occur when HA filler is placed too superficially beneath thin under-eye skin. This is a technique-dependent complication rather than a product defect, which is one reason why injector experience matters significantly for tear trough treatments.
Rare but Serious Complications
While uncommon, serious complications have been documented in the medical literature. A peer-reviewed review in PubMed Central describes the most significant risks:
Vascular occlusion — filler inadvertently compresses or enters a blood vessel, cutting off blood flow
Tissue necrosis — death of skin tissue if blood supply is compromised
Vision changes — in extremely rare cases, filler material can travel to retinal blood vessels
Vascular Occlusion: What You Need to Know
Research estimates the incidence of vascular occlusion at approximately 1 per 5,000 syringes across all filler injection sites. Importantly, the same review notes that most reported cases of vision loss associated with fillers have occurred with injections to the nose, glabella, and forehead—not the tear trough area. No cases of vision loss have been reported from tear trough injections specifically in the reviewed literature.
This does not eliminate the risk entirely, but it provides context: the tear trough area, when treated by an experienced injector, carries a comparatively lower vascular risk profile than certain other facial zones.
Hyaluronidase is stocked on-site and immediately accessible
Your provider is trained in recognising and treating vascular occlusion
There is a clear emergency action plan
Non-negotiable safety check
If a provider does not have hyaluronidase available or cannot explain their emergency protocol, this is a reason to seek a different provider—regardless of price, convenience, or reputation.
Your Pre-Treatment Checklist
Use this checklist as a practical tool before committing to treatment. Each item can be verified during a consultation.
Verify Your Provider's Credentials
[ ] Board-certified in dermatology, plastic surgery, or oculoplastics (or local equivalent)
[ ] Specific training and documented experience with tear trough injections
[ ] If in Istanbul: verify credentials through Turkish medical board certification
Apply cold compresses gently (do not press hard on the treated area)
Sleep with your head slightly elevated to reduce swelling
Avoid strenuous exercise for 24–48 hours
Avoid rubbing or massaging the area unless instructed
Skip makeup directly on the injection sites for 12–24 hours
Signs of Complications to Watch For
Monitor for the following in the hours and days after treatment:
Persistent or worsening pain that does not respond to standard over-the-counter pain relief
Blanching (whitening) of skin near the injection site — may indicate compromised blood flow
Unusual vision changes — blurring, loss of vision, or visual disturbances
Skin discolouration that progresses beyond normal bruising
When to Seek Medical Attention
Seek immediate medical care if you experience
Sudden vision changes, severe pain that worsens after the procedure, or expanding blanching or discolouration near the injection site. These may indicate vascular compromise and require urgent intervention with hyaluronidase. Do not wait—contact your provider or go to an emergency department immediately.
Making Your Decision
Factors to Consider Before Proceeding
Before scheduling treatment, weigh:
Cause of your concern — is it volume loss, pigmentation, skin laxity, or fat herniation? Only volume loss responds well to filler.
Provider experience — the tear trough is an advanced injection area. Prioritise skill over price.
Realistic expectations — results vary and are temporary. Maintenance is required.
Emergency preparedness — confirm hyaluronidase availability and complication protocols.
Your medical history — disclose all conditions, medications, and previous treatments to your provider.
Post-procedure timeline — plan to remain in Istanbul for at least 7–10 days after treatment to allow initial healing and attend any follow-up appointments
Escalation plan — discuss with your provider what happens if complications arise after you return home, including remote consultation availability and referral to a local specialist
Even with a straightforward treatment, build buffer days into your travel itinerary. Having time to attend a follow-up appointment or address minor concerns before your flight reduces risk and stress.
Next Steps
If you have reviewed this checklist and feel prepared to move forward, the next step is a consultation with a qualified provider who can assess your individual anatomy and discuss a personalised treatment plan.